EP 113: Harnessing human genetics to discover co-evolved small molecule medicines with Dr. Jason Park, CEO of Empress Therapeutics

EP 233: Unlocking early detection in liver disease with data and genetics with Tim Jobson of Predictive Health Intelligence

EP 232: How ethics and law shape reproductive technology and AI in medicine with Glenn Cohen of Harvard Law School

EP 231: From polygenic scores to AI-driven medicine with Andrea Ganna of the Institute for Molecular Medicine Finland

EP 230: From short reads to long reads in clinical genomics with Anna Lindstrand of Karolinska Institute

EP 229: Turning personal tragedy into a movement for preventive genetics with Matthew Goldstein of jscreen

EP 228: What genomes reveal about Epstein–Barr virus and human disease with Ryan Dhindsa and Caleb Lareau

EP 227: Discovering a new neurodevelopmental syndrome in the non-coding genome with Nicky Whiffin of the University of Oxford

EP 226: Scaling AAV gene therapy: Engineering delivery, safety, and cost with David Dismuke of Forge Biologics and Steven Gray of UT Southwestern

EP 225: Lessons from 20 years of building ocular gene therapies with Daniel Chung of Beacon Therapeutics

EP 224: Genomic newborn screening in Australia: From pilot studies to population-scale programs with Zornitza Stark of the University of Melbourne